BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 26741346)

  • 21. Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients.
    Powrózek T; Krawczyk P; Nicoś M; Kuźnar-Kamińska B; Batura-Gabryel H; Milanowski J
    Clin Transl Oncol; 2016 Apr; 18(4):398-404. PubMed ID: 26311076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic regulation of Wnt signaling pathway gene SRY-related HMG-box 17 in papillary thyroid carcinoma.
    Li JY; Han C; Zheng LL; Guo MZ
    Chin Med J (Engl); 2012 Oct; 125(19):3526-31. PubMed ID: 23044318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum DNA as a tool for cancer patient management.
    Ramirez JL; Taron M; Balaña C; Sarries C; Mendez P; de Aguirre I; Nuñez L; Roig B; Queralt C; Botia M; Rosell R
    Rocz Akad Med Bialymst; 2003; 48():34-41. PubMed ID: 14737938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal methylation of the sex-determining region Y-box 17 (SOX17) promoter predicts poor prognosis in myelodysplastic syndrome.
    Fan R; Zhao XL; Wang H; He HY; Peng ZP; Yang B; Han T; Wang W; Wang XQ; Lin GW
    Clin Lab; 2014; 60(9):1465-74. PubMed ID: 25291942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down-regulation of PAX6 by promoter methylation is associated with poor prognosis in non small cell lung cancer.
    Zhang X; Yang X; Wang J; Liang T; Gu Y; Yang D
    Int J Clin Exp Pathol; 2015; 8(9):11452-7. PubMed ID: 26617874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CST6 promoter methylation in circulating cell-free DNA of breast cancer patients.
    Chimonidou M; Tzitzira A; Strati A; Sotiropoulou G; Sfikas C; Malamos N; Georgoulias V; Lianidou E
    Clin Biochem; 2013 Feb; 46(3):235-40. PubMed ID: 23006792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients.
    Esteller M; Sanchez-Cespedes M; Rosell R; Sidransky D; Baylin SB; Herman JG
    Cancer Res; 1999 Jan; 59(1):67-70. PubMed ID: 9892187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct comparison study of DNA methylation markers in EpCAM-positive circulating tumour cells, corresponding circulating tumour DNA, and paired primary tumours in breast cancer.
    Chimonidou M; Strati A; Malamos N; Kouneli S; Georgoulias V; Lianidou E
    Oncotarget; 2017 Sep; 8(42):72054-72068. PubMed ID: 29069768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma EGFR T790M ctDNA status is associated with clinical outcome in advanced NSCLC patients with acquired EGFR-TKI resistance.
    Zheng D; Ye X; Zhang MZ; Sun Y; Wang JY; Ni J; Zhang HP; Zhang L; Luo J; Zhang J; Tang L; Su B; Chen G; Zhu G; Gu Y; Xu JF
    Sci Rep; 2016 Feb; 6():20913. PubMed ID: 26867973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.
    Soria JC; Lee HY; Lee JI; Wang L; Issa JP; Kemp BL; Liu DD; Kurie JM; Mao L; Khuri FR
    Clin Cancer Res; 2002 May; 8(5):1178-84. PubMed ID: 12006535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylation analysis for multiple gene promoters in non-small cell lung cancers in high indoor air pollution region in China.
    Huang X; Wu C; Fu Y; Guo L; Kong X; Cai H
    Bull Cancer; 2018 Sep; 105(9):746-754. PubMed ID: 30126609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of RASSF1A promoter hypermethylation in serum DNA of non-small cell lung cancer].
    Yu ZH; Wang YC; Chen LB; Song Y; Liu C; Xia XY; Lin Q; Ma CY
    Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):284-7. PubMed ID: 18788633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of aberrant Wnt7a promoter methylation in human non-small cell lung cancer in Koreans.
    Kim TH; Moon JY; Kim SH; Paik SS; Yoon HJ; Shin DH; Park SS; Sohn JW
    J Korean Med Sci; 2015 Feb; 30(2):155-61. PubMed ID: 25653486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Panel of Novel Detection and Prognostic Methylated DNA Markers in Primary Non-Small Cell Lung Cancer and Serum DNA.
    Ooki A; Maleki Z; Tsay JJ; Goparaju C; Brait M; Turaga N; Nam HS; Rom WN; Pass HI; Sidransky D; Guerrero-Preston R; Hoque MO
    Clin Cancer Res; 2017 Nov; 23(22):7141-7152. PubMed ID: 28855354
    [No Abstract]   [Full Text] [Related]  

  • 35. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients.
    Balgkouranidou I; Matthaios D; Karayiannakis A; Bolanaki H; Michailidis P; Xenidis N; Amarantidis K; Chelis L; Trypsianis G; Chatzaki E; Lianidou ES; Kakolyris S
    Mutat Res; 2015 Aug; 778():46-51. PubMed ID: 26073472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma cell-free DNA methylation combined with tumor mutation detection in prognostic prediction of patients with non-small cell lung cancer (NSCLC).
    Guo D; Yang L; Yang J; Shi K
    Medicine (Baltimore); 2020 Jun; 99(26):e20431. PubMed ID: 32590728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas.
    Virmani AK; Rathi A; Sathyanarayana UG; Padar A; Huang CX; Cunnigham HT; Farinas AJ; Milchgrub S; Euhus DM; Gilcrease M; Herman J; Minna JD; Gazdar AF
    Clin Cancer Res; 2001 Jul; 7(7):1998-2004. PubMed ID: 11448917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylation screening of the TGFBI promoter in human lung and prostate cancer by methylation-specific PCR.
    Shah JN; Shao G; Hei TK; Zhao Y
    BMC Cancer; 2008 Oct; 8():284. PubMed ID: 18834524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Base-Position Error Rate Analysis of Next-Generation Sequencing Applied to Circulating Tumor DNA in Non-Small Cell Lung Cancer: A Prospective Study.
    Pécuchet N; Zonta E; Didelot A; Combe P; Thibault C; Gibault L; Lours C; Rozenholc Y; Taly V; Laurent-Puig P; Blons H; Fabre E
    PLoS Med; 2016 Dec; 13(12):e1002199. PubMed ID: 28027313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer.
    Chang YS; Wang L; Liu D; Mao L; Hong WK; Khuri FR; Lee HY
    Clin Cancer Res; 2002 Dec; 8(12):3669-75. PubMed ID: 12473575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.